These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22072023)

  • 1. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.
    Lertnawapan R; Bian A; Rho YH; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2012 Mar; 21(3):279-87. PubMed ID: 22072023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
    Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
    Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis.
    Lertnawapan R; Bian A; Rho YH; Kawai VK; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    J Rheumatol; 2011 Nov; 38(11):2297-300. PubMed ID: 21844147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
    Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
    Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
    Rho YH; Solus J; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):535-41. PubMed ID: 20890983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.
    Ormseth MJ; Swift LL; Fazio S; Linton MF; Raggi P; Solus JF; Oeser A; Bian A; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2013 Jan; 22(1):26-33. PubMed ID: 23060481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus?
    Peixoto L; Aguiar P; de Bragança R; Martins JR; Acabado AJ; Ducla-Sores JL
    Acta Med Port; 2015; 28(3):333-41. PubMed ID: 26421786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.
    Baker JF; Morales M; Qatanani M; Cucchiara A; Nackos E; Lazar MA; Teff K; von Feldt JM
    J Rheumatol; 2011 Nov; 38(11):2369-75. PubMed ID: 21885493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of resistin as a marker of inflammation in systemic lupus erythematosus.
    Almehed K; d'Elia HF; Bokarewa M; Carlsten H
    Arthritis Res Ther; 2008; 10(1):R15. PubMed ID: 18234104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
    Sharma S; Denburg MR; Furth SL
    Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis and renal disease involvement in patients with systemic lupus erythematosus: a cross-sectional cohort study.
    Hermansen ML; Sandholt B; Fuchs A; Sillesen H; Køber L; Kofoed KF; Faurschou M; Jacobsen S
    Rheumatology (Oxford); 2018 Nov; 57(11):1964-1971. PubMed ID: 30016488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
    Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
    Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index.
    Vupputuri S; Fox CS; Coresh J; Woodward M; Muntner P
    Am J Kidney Dis; 2009 Jun; 53(6):993-1001. PubMed ID: 19394726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
    Romero-Díaz J; Acosta-Hernández RI; Criales-Vera S; Kimura-Hayama E; Domínguez-Quintana M; Morán-Contla R; Núñez-Alvarez C; Lara-Reyes P; Aguilar-Salinas C; Sánchez-Guerrero J
    J Rheumatol; 2018 May; 45(5):663-670. PubMed ID: 29545452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.
    Carlucci PM; Purmalek MM; Dey AK; Temesgen-Oyelakin Y; Sakhardande S; Joshi AA; Lerman JB; Fike A; Davis M; Chung JH; Playford MP; Naqi M; Mistry P; Gutierrez-Cruz G; Dell'Orso S; Naz F; Salahuddin T; Natarajan B; Manna Z; Tsai WL; Gupta S; Grayson P; Teague H; Chen MY; Sun HW; Hasni S; Mehta NN; Kaplan MJ
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.
    Rho YH; Chung CP; Oeser A; Solus J; Raggi P; Gebretsadik T; Shintani A; Stein CM
    J Rheumatol; 2008 Sep; 35(9):1789-94. PubMed ID: 18634156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.